Jan Broekroelofs

Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates

A. H. L. Mulder, Jan Broekroelofs, Gerda Horst et al. · Clinical & Experimental Immunology · 1994 · 90 citations · Full text

Veterinary Medicine, Immunology, Pathology +17

Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Janneke Tuin, Patricia M. Stassen, I. Daria Bogdan et al. · Clinical Journal of the American Society of Nephrology · 2019 · 73 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial

Jan‐Stephan Sanders, Anoek A. E. de Joode, Ruud G. DeSevaux et al. · Nephrology Dialysis Transplantation · 2016 · 66 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +15

LONG-TERM RENAL OUTCOME AFTER LUNG TRANSPLANTATION IS PREDICTED BY THE 1-MONTH POSTOPERATIVE RENAL FUNCTION LOSS

Jan Broekroelofs, Gerjan Navis, Coen A. Stegeman et al. · Transplantation · 2000 · 64 citations

Medicine, Nephrology, Surgery +16

Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD)

Jan Broekroelofs, A. H. L. Mulder, G.F. Nelis et al. · Digestive Diseases and Sciences · 1994 · 62 citations

Life Sciences, Immunology, Pathology +14